Antisense Therapeutics Limited
ATHJF · OTC
6/30/2024 | 12/30/2023 | 6/30/2023 | 12/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,176 | -$4,743 | -$6,107 | -$5,273 |
| Dep. & Amort. | $32 | $47 | $48 | $47 |
| Deferred Tax | $0 | $0 | -$668 | $0 |
| Stock-Based Comp. | $91 | $54 | $17 | $90 |
| Change in WC | -$857 | $0 | $555 | $0 |
| Other Non-Cash | $2,540 | -$44 | $549 | $2,775 |
| Operating Cash Flow | -$5,370 | -$4,834 | -$5,606 | -$2,546 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $3 | -$7 | -$7 | -$23 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $3 | -$7 | -$7 | -$23 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $11,108 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $41 | $5,489 | -$22 | -$21 |
| Financing Cash Flow | $41 | $11,067 | -$43 | -$42 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,326 | $6,226 | -$5,656 | -$2,610 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,193 | $10,967 | $16,623 | $19,233 |
| End Cash | $11,867 | $17,193 | $10,967 | $16,623 |
| Free Cash Flow | -$5,367 | -$4,841 | -$5,612 | -$2,568 |